skip to main content
covidend_logo_color

Our network of sites

Synthesizing working group

 
This working group supports efforts to synthesize the evidence that already exists in ways that are more coordinated and efficient and that balance quality and timeliness

Terms of reference

  1. Contribute to the development and maintenance of the resources and tools for researchers considering and conducting COVID-19 evidence syntheses and encouraging its use by researchers and evidence users to avoid unnecessary duplication
  2. Encourage updating or extending existing reviews in conjunction with other interested groups within and beyond COVID-END
  3. Share evidence tables that can be used in local guideline-development processes (or local evidence-contextualization processes more generally)
  4. Identify and promote guidance and expectations for conducting and reporting all the different forms of evidence synthesis that may be used to inform decisions and address issues related to COVID-19
  5. Promote and share the quality assurance, publishing, translation and other benefits that come from working with major international evidence producers and publishers and considering how these should be applied in the context of COVID-19
  6. Draft guidance for and promote living reviews (and living guidelines) where appropriate as an emerging standard for evidence synthesis in the context of COVID-19, ensuring that these encompass different content areas, intervention and review types

Participants

  1. David Tovey, COVID-END Secretariat (co-chair)
  2. Taryn Young, Centre for Evidence-based Health Care, Stellenbosch University, South Africa (co-chair)
  3. Andrea Tricco, SPOR Evidence Alliance, Canada
  4. Birte Snilsveit, 3IE, UK
  5. Cristián Mansilla, McMaster University, Canada
  6. Cheow Peng Ooi, University of Putra, Malaysia
  7. David Nunan, Oxford Centre for Evidence Based Medicine, UK
  8. Edoardo Aromataris, Joanna Briggs Institute, Australia
  9. Elie Akl, Systematic Review Centre for Health Policy and Systems, AUB, Lebanon
  10. Kamga Emmanuel Berinyuy, eBase, Cameroon
  11. Karla Soares-Weiser, Cochrane, Israel
  12. Gabriel Rada, Epistemonikos, Chile
  13. Gunn Vist, Norwegian Institute of Public Health, Norway
  14. Isabelle Boutron, Cochrane France, France
  15. Nikita Burke, Cochrane Ireland, Ireland
  16. Simon Lewin, Norwegian Institute for Public Health, Norway
  17. Stephanie Chang, Agency for Healthcare Research and Quality, USA
  18. Vivian Welch, Campbell Collaboration, Canada
  19. Secretariat: Safa Al-Khateeb, McMaster Health Forum | RISE, Canada and Anna Dion, Ottawa Hospital Research Institute | RISE, Canada

Meeting documents

Meeting date Documents
September 16, 2020
  1. Agenda
  2. Core outcomes survey
  3. Core outcomes set for COVID-19 trial
  4. Notes
September 9, 2020
  1. Agenda
  2. Notes
August 26, 2020
  1. Agenda
  2. COS survey
  3. COS workshop
  4. Notes
August 14, 2020
  1. Agenda
  2. Notes
July 22, 2020
  1. Agenda
  2. Improve my RIS
  3. Notes
July 15, 2020
  1. Agenda
  2. Rapid review during COVID-19
  3. Notes
July 8, 2020
  1. Agenda
  2. COVID-END inventory
  3. Notes
June 24, 2020
  1. Agenda
  2. Notes
June 17, 2020
  1. Agenda
  2. Next generation presentation
  3. Terms of reference
  4. Notes
June 10, 2020
  1. Agenda
  2. Resources and tools
  3. Terms of reference
  4. Notes
June 3, 2020
  1. Agenda
  2. Resources and tools
  3. Key quality standards
  4. Notes
May 27, 2020
  1. Agenda
May 20, 2020
  1. Agenda
  2. Resources and tools for evidence synthesis
  3. Notes
May 13, 2020
  1. Agenda
  2. Resources and tools for evidence synthesis
  3. Notes
May 7, 2020
  1. Agenda
  2. Notes
May 1, 2020
  1. Agenda
  2. Notes

Use the interactive flow diagram to find resources for researchers considering and conducting COVID-19 evidence syntheses.